openPR Logo
Press release

Human Coagulation Factor VII Market Analysis Report, Share, Growth, Trend, and Forecast, 2025

06-01-2017 10:17 PM CET | Health & Medicine

Press release from: Transparency Market Research

Human Coagulation Factor VII Market Analysis Report, Share,

Human coagulation factor VII is a single chain plasma glycoprotein that initiates the process of blood clotting in the coagulation cascade. It belongs to the enzyme serine protease family. Factor VII is produced in the liver and then circulated in the plasma where it comes in contact with the tissue factor, an integral membrane protein. After binding, factor VII is converted into factor VIIa which further initiates the coagulation pathway. A factor VII deficiency (a disorder wherein the body is not able to produce factor VII) leads to a condition where blood is unable to clot, causing excessive and prolonged bleeding after a surgery or injury. This deficiency is either acquired or inherited – the former after birth, which may be a result of the effect of medication or diseases which interfere with the production of factor VII such as liver diseases and vitamin K deficiency. Major symptoms associated with factor VII deficiency are longer duration of bleeding caused by wounds, bleeding joints, bleeding gums, and heavy menstrual periods. Diagnosis is mostly accomplished through lab tests such as factor assay, inhibitor tests, and prothrombin time (PT) to measure the functioning of factors I, II, V, VII, and X.

Get accurate market forecast and analysis on the Human Coagulation Factor VII Market . Request a sample to stay abreast on the key trends impacting this market.

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=24074

Hemophilia is an inherited medical condition in which the patient’s blood is unable to clot. The symptoms could be mild to severe. In severe cases, patients experience internal bleeding. Treatment of hemophilia is usually in the form of medication for genetically engineered factor VII to prevent and treat prolonged bleeding. The rising incidence of hemophilia is a major driver of the human coagulation factor VII market, apart from initiatives taken by governments to create awareness regarding its prevention and treatment and the advent of new techniques for the development of safer and cost-effective products. Limited awareness in the medical profession and among policy makers about the medical conditions in which human coagulation factors VII can be used is a major restraining factor for this market.

The global human coagulation factor VII market has been categorized based on product type into the following categories: recombinant factor VII and plasma-derived factor VII. The former is anticipated to dominate the market due to the safety and efficiency associated with the use of the recombinant product as compared to plasma-derived factor VII. However, improvements in viral inactivation and advanced screening method have greatly improved the safety aspect of plasma-derived factor VII. In terms of application, the global human coagulation factor VII market has been segmented into the following sections: hemophilia, surgery, and others. Hemophilia is predicted to lead the market, followed by surgery. By end-user, the market has been divided into the following groups: hospitals, ambulatory surgery centers, specialty clinics, and others.

View Report @ http://www.transparencymarketresearch.com/human-coagulation-factor-vii-market.html

Geographically, the global human coagulation factor VII market is distributed over North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is a major market, followed by Europe. The rising number of hemophilia patients, surge in health care expenditure, and increasing awareness about hemophilia created by government organizations in developed countries are factors contributing to the expansion of the market in this region. The hemophilia population in developing countries accounts for about 80% of the global hemophilia population and is projected to emerge as a lucrative market owing to the increasing efforts taken by government organizations to create awareness and the involvement of NGOs to create better health care facilities and educate patients regarding available treatment.

Key players in the global market include Baxter International Inc, Bayer AG, Pfizer Inc., CSL Behring, Grifols USA, LLC, Novo Nordisk, Octapharma AG, ProSpec- Tany Technogene Ltd., Enzyme Research Laboratories, and others.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Human Coagulation Factor VII Market Analysis Report, Share, Growth, Trend, and Forecast, 2025 here

News-ID: 560807 • Views: 312

More Releases from Transparency Market Research

Adaptogenic Beverages Market To Register High Revenue Growth During 2019 - 2027
Adaptogens, special class of non-toxic substances or plant extracts that help the body adapt to stress, have recently witnessed a gradual increase in demand. As consumers across the globe are shifting towards products that contain ingredients to boost immunity and reduce stress, manufacturers in the food industry are exploring the potential use of adaptogenic herbs as food and beverage ingredients. The rise in the popularity of adaptogens has brought on
Tea Tree Oil Market Booming By Size, Revenue And Trend In 2028 Scrutinized In Ne …
The global tea tree oil market is expected to witness healthy growth during 2018-2026. Tea tree is also known as melaleuca. The tree is largely known for its several antiseptic benefits. Tree tree oil is enjoying an increased prominence worldwide, thanks to its ability to kill several strains of bacteria, fungi, and virus. The original plant used to obtain tea tree oil is found in Australia and its complete scientific
Petroleum Dyes Market Analysis and Value Forecast Snapshot by End-use Industry 2 …
Introduction Petroleum dyes are materials that are used to add color to petroleum products, lubricating oils, and gasoline. These dyes are complex and unsaturated aromatic compounds that possess characteristics such as solubility, and intense color Markers are colorless ingredients that are added to fuels which can be perceived by adding precise reagent to add color. Commonly used petroleum dyes are azo dyes and alkyl dyes. Petroleum dyes are used to prevent
Tank Insulation Market Company Profiles, Financial Perspective, Top Technologies …
Tank insulation helps in covering of bulk storage tanks and jacketing to reduce heat loss or gain for large, flat-bottomed tank that store materials which are sensitive to temperature fluctuation Read Report Overview @ https://www.transparencymarketresearch.com/tank-insulation-market.html The source of heat for a boiler is combustion of any of the fuels such as wood, coal, oil, or natural gas. Tank insulation transfers the heat to water, which circulates through the radiators for heating purpose.

All 5 Releases


More Releases for VII

Global Human Coagulation Factor VII Sales Market Report 2018| Baxter, Bayer, Pfi …
Albany, NY, 24th July : Recent research and the current scenario as well as future market potential of "Global Human Coagulation Factor VII Sales Market Report 2018" globally. This report studies the global Human Coagulation Factor VII market status and forecast, categorizes the global Human Coagulation Factor VII market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe,
Global Human Coagulation Factor VII Market 2018 - NovoNordisk
Eminent Market, recently published a detailed market research study focused on the "Human Coagulation Factor VII Market" across the global, regional and country level. The report provides 360° analysis of "Human Coagulation Factor VII Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Human Coagulation Factor VII industry, and estimates the future
Human Coagulation Factor VII Market Size to Grow Exponentially during 2017 - 202 …
Human coagulation factor VII is a single chain plasma glycoprotein that initiates the process of blood clotting in the coagulation cascade. It belongs to the enzyme serine protease family. Factor VII is produced in the liver and then circulated in the plasma where it comes in contact with the tissue factor, an integral membrane protein. After binding, factor VII is converted into factor VIIa which further initiates the coagulation pathway.
Global Human Coagulation Factor VII Market Accounting a Higher Growth by 2017– …
Festive Month Offer - 20% discount on purchase of reports from 1st October to 31st October. https://www.researchtrades.com/discount/1249539 For more offers post 31st October, kindly contact us. * Terms & Conditions apply!! Contact No. : +16269994607 (US), /+91 7507349866 (IND) Email: sales@researchtrades.com Report Overview: The “Global Human Coagulation Factor VII Market Research Report” is a professional and in-depth study on the current state of the Human Coagulation Factor VII Market. The study offers an insight into current
Human Coagulation Factor VII Market Size, Status and Forecast 2025
Human coagulation factor VII is a single chain plasma glycoprotein that initiates the process of blood clotting in the coagulation cascade. It belongs to the enzymeserine protease family. Factor VII is produced in the liver and then circulated in the plasma where it comes in contact with the tissue factor, an integral membrane protein. After binding, factor VII is converted into factor VIIa which further initiates the coagulation pathway. A
Human Coagulation Factor VII Market 2017 : Startup Strategy Resources, Grow Pric …
The recent report of Market Research Store on the “Human Coagulation Factor VII Market Research” has the complete assessment of the latest trends of the global Human Coagulation Factor VII market. The report focuses on the manufacturing challenges that are being faced and provides the solutions and the strategies that have been implemented to overcome the problems. Deep researches and analysis were done during the preparation of the report. The information